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Abstract
Background: The epidemic pattern of respiratory syncytial virus (RSV) is quite different in regions
of Europe (biennial epidemics in alternating cycles of approximately 9 and 15 months) than in the
Western Hemisphere (annual epidemics). In order to determine if these differences are accounted
for by the circulation of different RSV subtypes, we studied the prevalence of RSV subtype A and
B strains in Zagreb County from 1 January 2006 to 31 December 2007.
Results:  RSV was identified in the nasopharyngeal secretions of 368 inpatients using direct
fluorescence assays and/or by virus isolation in cell culture. The subtype of recovered strains was
determined by real-time PCR. Of 368 RSV infections identified in children during this interval,
subtype A virus caused 94 infections, and subtype B 270. Four patients had a dual RSV infection
(subtypes A and B).
The period of study was characterized by two epidemic waves of RSV infections-one, smaller, in
the spring of 2006 (peaking in March), the second, larger, in December 2006/January 2007 (peaking
in January). The predominant subtype in both outbreaks was RSV subtype B. Not until November
2007 did RSV subtype A predominate, while initiating a new outbreak continuing into the following
calendar year.
Conclusion: Though only two calendar years were monitored, we believe that the biennial RSV
cycle in Croatia occurs independently of the dominant viral subtype.
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Background
Respiratory syncytial virus (RSV) causes major outbreaks
of acute respiratory infections (ARIs) in children and
adults. Infections manifest themselves as mild upper res-
piratory tract infections (URTIs) or lower respiratory tract
infections (LRTIs): bronchitis, bronchiolitis, and pneu-
monia [1-3]. RSV outbreaks occur, in moderate climates,
in winter/early spring months. A multiannual epidemio-
logical study of RSV infections in Croatia has shown that
these infections have a repeated biennial pattern [4]. The
outbreaks alternated in a predictable cycle, peaking in
December/January of 1994/95, 1996/97, 1998/99, 2000/
01, 2002/03, 2004/05 and 2006/07, and every March/
April during 1996, 1998, 2000, 2002, 2004 and 2006 [4-
6]. Thus there is a two-year RSV cycle in Croatia repeating
every 23 to 25 months. After a major RSV outbreak begin-
ning in December/January, there ensues a minor one
beginning 14 to16 months later (March/April peak), fol-
lowed again by a major outbreak in another eight to ten
months [4]. The same pattern of RSV outbreaks was also
noted in Germany, Switzerland, Finland and Sweden [7-
11]. Unlike Central Europe, Great Britain experiences a
monophasic, annual RSV epidemic cycle [12]. In three
geographically diverse regions of the United States (New
York, Tennessee, Ohio), RSV infection cycles are also
monophasic and annual [13,14]. RSV has two subtypes, A
and B, that are distinguished largely by differences in the
viral attachment (G) protein or the nuclear (N) protein.
During epidemics, either subtype A or B may predomi-
nate, or both subtypes may circulate concurrently [13,14].
For example, in studies over a seven-year interval in South
America, a monophasic RSV infection cycle was noted in
Brazil, with a dominant subtype A [15], while Argentina
registered an alternating annual domination between sub-
types A and B [16]. The aim of this paper was to determine
if differences in circulating RSV subtypes accounted for
the established two-year cycles in Zagreb County.
Patients and methods
The study was conducted as part of the scientific project
#0005002, approved by the ethics committees of the
Croatian National Institute of Public Health (CNIPH), the
University Children's Hospital Zagreb and the University
Infectious Disease Hospital in Zagreb. The study period
lasted from 1 January 2006 to 31 December 2007. The
study included all children (from birth to 18 years) with
proven RSV ARIs. The subjects all came from Zagreb
County and were hospitalized in the Zagreb University
Children's Hospital and Infectious Disease Hospital. They
were included into the study after a written consent had
been obtained from their parents or caretakers.
RSV was identified in nasopharyngeal secretions (NPS) of
patients by detection with monoclonal antibodies, using
a direct fluorescence assay (DFA-Light Diagnostics,
Chemicon International, Inc., Temecula, CA) or/and virus
isolation in cell culture (Hep-2, HeLa, MRC-5) [17,18] at
the Department of Virology, CNIPH.
Molecular diagnosis was performed by Real-Time RT PCR.
RNA was extracted from NPS using a spin column kit
(QIAamp DNA Mini Kit; QIAGEN GmbH, Hilden). A
one-step real-time PCR assay was performed for detection
of viral RNA using a single-tube RT-PCR kit (TaqMan One-
Step RT-PCR Master Mix Reagents Kit; Applied Biosys-
tems, New Jersey, USA). Amplification and detection were
performed with a 7500 Real Time PCR System machine
(Applied Biosystems). The N gene of RSV A and of RSV B
were targeted with primers and probes (as listed below),
according to van Elden et al. [19], with minor modifica-
tions of the reverse primer for RSV A. Each tube contained
a 25-μl reaction mix which included 2.5 μl of isolated
RNA, 0.9 μM forward primer, 0.9 μM reverse primer and
0.25  μM probe. Primers and probes for the TaqMan
amplification of viral RNA from RSV A and B were:
RSV A (N gene)
f: AGATCAACTTCTGTCATCCAGCAA
r: TGTGTTTCTGCACATCATAATTAGGA
probe: FAM-ACACCATCCAACGGAGCACAGGAGA-
TAMRA.
RSV B (N gene)
f: AAGATGCAAATCATAAATTCACAGGA
r: TGATATCCAGCATCTTTAAGTATCTTTATAGTG
probe: FAM-AGGTATGTTATATGCTATGTCCAGGTTAG-
GAAGGGAA-TAMRA.
Statistical analysis was performed using STATISTICA for
Windows, StatSoft, Inc. (1999), Tulsa, OK, USA. Chi-
squared test for proportions and Mann-Whitney U test for
age were used for group comparisons; differences with
probabilities <0.05 were considered to be significant.
Results
From January 2006 to December 2007 in Zagreb County,
RSV infections were proved in 368 (162 girls and 206
boys) children aged 0-18 years. Only 6 of them (1.63%)
were above 5 years while the majority (315/368 or
85.6%) were 0-2 years old (Table 1). Over one half of
proved RSV infections occurred in children up to 6
months of age (188/368, i.e. 51.01%). The largest number
of RSV-positive patients had a clinical picture of bronchi-
olitis (173, 47.01%), then URTI (108, 29.35%), bronchi-
tis (53, 14.40%), pneumonia (37, 10.05%) and croup (2,
0.54%). RSV bronchiolitis and bronchitis were mostlyVirology Journal 2009, 6:133 http://www.virologyj.com/content/6/1/133
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found among younger children (median ages were 0.25
and 0.75 years, respectively), while URTI were identified
more in slightly older children (median age 1.08 years)
and pneumonia was diagnosed most commonly among
even older patients (median age was 2.25 years). Among
RSV-positive inpatients under the age of 12 months, bron-
chiolitis was diagnosed in 162/254, or 63.78%.
In the entire period encompassing 2006 and 2007, sub-
type B RSV infections were proved almost three times
more frequently than group A infections (270, or 73.4%,
vs. 94 patients, or 25.5%, respectively, p < 0.001, Table 1).
Subjects with subtype A or subtype B infection did not dif-
fer significantly by age. The median age for RSV patients
infected by subtypes A and B were 0.58 and 0.50 years,
respectively (p = 0.485).
Boys were more frequently infected by subtype B than
girls. That is, subtype B was the causative agent in 160 out
of 203 (88.8%) infected boys and in 110 out of 161
(68.3%) infected girls (p = 0.023). Although the age dis-
tribution of inpatients infected with subtype A or B did
not differ significantly (as stated above), subtype B strains
appeared to infect boys under the age of 12 months more
frequently than girls of the same age (Table 1). That is,
81.8% (121/148) of RSV infections occurring in males <
12 months of age were subtype B, whereas only 68.6%
(70/102) RSV infections in girls of the same age were sub-
type B (p = 0.016). Among children above one year of age,
subtype B infections accounted for 70.9% (39/55) of
infections in males, and 67.8% (40/59) of infections in
girls (p = 0.718). Four patients (0.01%) had double RSV
infections (subtypes A and B) (Table 1); three were boys.
Two infants with double RSV infections had bronchiolitis;
the remaining two had bronchitis and URTI respectively.
Bronchiolitis was caused by subtype B virus in 131/173
(75.7%) patients with this diagnosis, of whom 123 were
infants (93.89%). Bronchiolitis was caused by RSV sub-
type A in 40 patients (23.1%), of whom 37 were infants
(92.50%, Figure 1). Subtype B caused severe LRTIs (bron-
chiolitis and pneumonia) in 159/270 (58.9%) of those
Table 1: Respiratory syncytial virus infections in Croatia in 2006 and 2007 by viral subtype, age, sex and clinical syndrome
URTI* Bronchiolitis Pneumonia Bronchitis Croup Total
A B A+B A B A+B A B A B A+B B A B A+B Total
0-6 months M 7 12 12 64 1 3 1 8 1 20 88 1 109
F3 6 2 0 3 9 1 1 2 6 1 2 6 5 2 1 79
6-12 months M 2 10 1 2 15 2 3 6 1 7 33 2 42
F2 8 35 1 5 6 1 8 24
1-2 yrs M 6 11 1 3 2 4 1 7 10 25 35
F5 5 23 5 2 4 9 1 7 26
2-5 yrs M 4 7 2 1 2 1 1 6 12 18
F 38 4 1 013 82 1 29
5-10 yrs M 1 1 2 2
F1 1 1 12 3
>10 yrs F 1 1 1
Total M 19 40 1 15 84 1 3 12 6 23 1 1 43 160 3 206
F1 5 2 8 2 54 7 1 6 1 65 1 8 1 5 1 1 1 0 1 162
Grand Total 34 68 1 40 131 2 9 28 11 41 1 2 94 270 4 368
*URTI-Upper respiratory tract infectionVirology Journal 2009, 6:133 http://www.virologyj.com/content/6/1/133
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Bronchiolitis and pneumonia (No.) caused by respiratory syncytial virus in Croatia in 2006 and 2007 by viral subtype and age Figure 1
Bronchiolitis and pneumonia (No.) caused by respiratory syncytial virus in Croatia in 2006 and 2007 by viral 
subtype and age.
0
20
40
60
80
100
120
140
BP BP BP BP BP
0-6 months 6-12 months 1-2 yrs 2-5 yrs 5-10 yrs
B=Bronchiolitis   P=Pneumonia
B
A
Respiratory syncytial virus (subtypes A and B) infection occurrence (No.) by calendar week in three epidemic waves during  2006 and 2007 (1 January 2006 to 31 December 2007) Figure 2
Respiratory syncytial virus (subtypes A and B) infection occurrence (No.) by calendar week in three epidemic 
waves during 2006 and 2007 (1 January 2006 to 31 December 2007).
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subjects with proved infections caused by this subtype.
Subtype A caused bronchiolitis or pneumonia in 49/94
cases (52.1%, p = 0.25, Table 1).
The year 2006 saw two epidemic waves of RSV infections.
As shown in Figure 2, the first (smaller) wave began in the
spring of 2006. This epidemic originated in January,
peaked in March, and ended in May 2006. The second
(larger) wave began in the winter of 2006/2007, starting
in November 2006, peaking in January 2007, and ending
in May 2007. Importantly, the predominant circulating
virus in each of these outbreaks was subtype B. The ratio
of RSV subtypes (A:B) was 22:105 (82.7% subtype B) for
the first 2006 outbreak and 45:169 (79.0% subtype B) for
the second, larger epidemic (p = 0.405); 4 patients with
double infections were included in the analysis.
In the larger outbreak during 2006/2007, the subtype B
wave started earlier and lasted longer than the subtype A
epidemic. In the smaller spring 2006 outbreak, both sub-
types began circulating at the same time, but subtype A
activity terminated slightly earlier (Figure 2). In the first,
smaller outbreak in 2006, the activity of subtype A was
fairly constant over an interval of 14-15 weeks. In the sec-
ond, larger outbreak both subtypes exhibited a more char-
acteristic epidemic peak in January 2007 (Figure 2).
In November 2007 a new RSV epidemic began. In the first
two months of this new outbreak, only subtype A virus
was recovered.
Discussion
The present study confirms the continued wintertime epi-
demic activity of RSV in Croatia. It also confirms the
unique biennial pattern of RSV activity that is reported in
Central Europe [4,7-9], but differs markedly from that
observed in North and South America and Great Britain
[12-16]. Many earlier studies have attempted to explain
the epidemic pattern of RSV activity. Despite numerous
investigations of the potential effects of climate and
human behavior on RSV epidemics, no coherent explana-
tion exists. RSV is known to exist in two subtypes, differ-
ing principally in the structure of the G or N proteins of
the virus. We undertook this study to determine if the cir-
culation of different subtypes might explain the biennial
pattern of RSV epidemics in Croatia.
We found the anticipated biennial circulation of RSV in
the period from January 1, 2006 through December 31,
2007 with subtype B strains of RSV predominating
throughout. Subtype B accounted for 82.7% of infections
in the smaller epidemic (March/April peak of 2006), and
79.0% of the cases in the larger one (December 2006/Jan-
uary 2007 peak). Although subtype B, in the larger out-
break, started circulating slightly earlier and its epidemic
wave lasted somewhat longer than for subtype A, both
RSV subtypes had the same pattern of activity in each out-
break. This occurred despite the fact subtype B infections
were far more common (four times) than subtype A infec-
tions in these two outbreaks. Although we studied only a
brief time interval, these findings lend doubt to the idea
that subtype differences account for the existence of alter-
nating epidemics.
In our study subtype B infection was more frequent than
subtype A infection in both males and females. However,
subtype B infections occurred more frequently in males
less than 12 months of age than in females of the same
age, while the frequency of infection with the two sub-
types became equal in the two genders after 12 months of
age. Our previous study of RSV activity over eleven consec-
utive years showed that the rate of RSV-related hospitali-
zations was higher in boys (59%) than in girls. However
the predominance of RSV infection in males versus
females was also observed among those with URTI as well
as LRTI, and also among subjects with infection due to
other viruses or those cases in which no virus was detected
[20]. Thus we would expect the overall predominance of
subtype B in males, because this subtype was the prevalent
strain during the time of our study. We suspect that the
equalization of RSV infection among older children is
attributable to the smaller number of cases of children
hospitalized after infancy. However it is known that air-
flows are lower in the lungs of male infants than female
infants [21], so we cannot exclude an interaction of sub-
type B infection with male gender and congenitally lower
in causing the higher rate of hospitalization for subtype B
RSV infection among males during infancy.
Subtype B was not only more common overall, but also a
more common causative agent of bronchiolitis and pneu-
monia than subtype A virus. Subtype B caused bronchioli-
tis and pneumonia in 58.88% cases, whereas group A
caused 52.12% cases. This differs from the findings of
Oliveira et al [15] in Brazil, where subtype A virus has pre-
dominated in the population for several years and more
commonly caused bronchiolitis and pneumonia
(54.68%) in comparison with subtype B (38.88%).
The results of the present study show that the cyclic nature
of RSV epidemics in Croatia in 2006 and 2007 is identical
to that of previous years [4,5]. We are now typing about
400 RSV strains that circulated in Zagreb county during
2008 to see whether subtype A (which dominated at the
end of 2007; Figure 2) was the major subtype circulating
through all of 2008. We already have data (yet unpub-
lished) that the RSV epidemic in 2007/2008 peaked in the
spring of 2008, while the following outbreak (2008/
2009) appeared to be peaking in December 2008/January
2009. The papers of North and South American authorsVirology Journal 2009, 6:133 http://www.virologyj.com/content/6/1/133
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demonstrate that monophasic cycles occur annually in
North and South America regardless of the dominant RSV
subtype. This supports the claim that the monophasic or
alternating patterns of RSV activity in these different coun-
tries are not determined by differences in the circulating
subtypes [13,15].
It has been established that RSV outbreaks in Croatia have
occurred in a two-year cycle for at least the past 15 years
[4-6]. The effects of air temperature and humidity on this
phenomenon were studied in northwest Croatia. Climate
conditions correlated only with those RSV seasons when
outbreaks peaked in December/January, and not with
those outbreaks which occurred in the spring (March/
April) [4]. An explanation for this variation has not been
identified, although the effects of one extensive epidemic
on partially immunizing infants, thereby postponing the
next epidemic and reducing it in size, has been consid-
ered. Other unknown characteristics of the European
mainland, such as environmental or geological features,
may also be responsible.
These findings on periodicity of RSV infections forecast
the beginning and end of all RSV epidemics, and are
important for planning the prevention and control of RSV
infections in the region [4,7-15], especially the timely sup-
ply and use of prophylactics (palivizumab). A greater
understanding of the factors that determine RSV activity
would make this timing even more precise. Subtype vari-
ations in circulating strains do not seem to be an impor-
tant determinant of RSV activity. Hopefully, in the future
another kind of prophylaxis, an effective vaccine, could
diminish the need for an accurate prediction of RSV out-
break, and the great burden of RSV infections generally.
Conclusion
Since the two-year periodicity of RSV infections in Croatia
could not be related to climatic factors [4], we examined
whether this epidemiological characteristic of RSV infec-
tions in Croatia could be related to a regular exchange of
the two viral subtypes. However, according to current
findings, it may be concluded that the predominant RSV
subtype has no effect on the periodicity of RSV infections
in Croatia.
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